Postpartum Mom Power for Opioid Use Disorder
Official title: Postpartum Intervention for Mothers With Opioid Use Disorders (R33)
Run by Stony Brook University · NCT07632053 · Data updated 2026-11-12
This study tests a Mother Power parenting program in moms with opioid use disorder to see if it helps reduce cravings, stress, and improve brain responses to infant cues compared with enhanced usual care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 50 Years |
| Sex | Women only |
| Enrollment | 80 (estimated) |
| Sponsor | Stony Brook University Academic / other |
| Locations | 2 sites (Ann Arbor, Michigan and 1 other locations) |
| Status | Recruiting |
| Started | July 1, 2025 |
| Main results expected | July 2028 |
| Study ends | July 2028 |
| Registry record updated | June 9, 2026 |
| Trial ID | NCT07632053 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Mothers with opioid use disorder (or on MAT) who have a child aged 5 or younger and can understand English.
✕Probably not a fit
May not benefit those without MRI compatibility or who do not respond to the intervention components.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a two-site randomized trial enrolling about 80 mothers per group to evaluate a maternal postpartum intervention called Mom Power (vMP) for those with opioid use disorder. Participants are assessed before and after the program with behavioral measures and brain imaging to explore changes in maternal brain networks, stress, mood, and cravings. The study compares vMP to enhanced usual care and examines whether brain and behavioral changes mediate any clinical benefits. Eligibility includes OUD diagnosis or MAT, a child aged 5 or younger, and English proficiency; MRI safety criteria apply. The trial is led by Stony Brook University with collaboration from the University of Michigan.
Why it matters
Potential benefit: If successful, the program could reduce maternal stress and cravings and improve mother–child interactions for mothers with OUD.
How similar studies have gone: Prior phases suggested potential brain and behavioral changes with this type of targeted parenting intervention in similar populations, supporting continued testing.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * mothers with diagnosis of Opioid Use Disorder (OUD); and/or receiving medication assisted treatment (such as buprenorphine or methadone) * with a child aged 5 or less * able to read, hear and understand English adequately enough to provide informed consent Exclusion Criteria: * require immediate clinical care for suicidal/homicidal risk or psychosis; * For magnetic resonance imaging (MRI) of the brain, potential participants will be excluded if they: (1) have ferromagnetic metal in their heads (2) have severe claustrophobia that prevents participation in the neuroimaging (3) have serious neurological condition that could interfere with neuroimaging, including a brain tumor, multiple sclerosis or significant head trauma
Where it's running
-
University of Michigan
Ann Arbor, Michigan, United States Recruiting -
Stony Brook University
Stony Brook, New York, United States Recruiting
Study contacts
- Principal investigator: James E Swain, MD, PhD — Stony Brook University
- Study coordinator: James E Swain, MD, PhD
- Email: james.swain@stonybrookmedicine.edu
- Phone: 516-838-7604
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
CBD for Opioid Dependence and Pain on Buprenorphine
This study tests whether different doses of cannabidiol (CBD) can affect pain and opioid cravings in adults with opioid use disorder who are on buprenorphine, using a short, randomized, placebo-controlled setup.
-
Cebranopadol for opioid withdrawal in adults with chronic pain
This study tests whether cebranopadol can reduce withdrawal symptoms in adults with chronic pain who are physically dependent on prescribed opioids, compared with placebo.
-
emPath platform pilot to link and keep adults with opioid use disorder in care in Durham
This pilot tests a mobile app and telemedicine approach to help adults with opioid use disorder start and stay in MOUD through community outreach in Durham, NC.
-
CB1 Receptors in Opioid Use Disorder Measured with a PET Radioligand
This study tests CB1 receptor availability in people with opioid use disorder starting opioid agonist therapy and compares them with healthy adults.
-
STORC: Training a support person plus patient navigation after birth
We’re testing whether training a designated support person and using patient navigation after delivery helps people with opioid use disorder build recovery resources and stay in treatment.
-
Personalized Addiction Treatment Enhancement for Opioid Use Disorder
A digital platform run by peer recovery supporters will be tested to help adults with opioid use disorder who are on buprenorphine or methadone stay in treatment and improve outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.